ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. Monash IVF Group's annualized return on capital (ROC %) for the quarter that ended in Dec. 2025 was 4.31%.
As of today (2026-06-25), Monash IVF Group's WACC % is 2.17%. Monash IVF Group's ROC % is 4.47% (calculated using TTM income statement data).
Monash IVF Group generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.
Monash IVF Group (ASX:MVF) ROC % Explanation
ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.
There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.
Why is ROC % important?
Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.
As of today, Monash IVF Group's WACC % is 2.17%. Monash IVF Group's ROC % is 4.47% (calculated using TTM income statement data).
Monash IVF Group generates higher returns on investment than it costs the company to raise the capital needed for that investment. It is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases.
Be Aware
Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Monash IVF Group ROC % Related Terms
Monash IVF Group ROC % Historical Data
* Premium members only.
The historical data trend for Monash IVF Group's ROC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note:
The Operating Income data used here is two times the semi-annual (Dec. 2025) data.
The tax rate is limited to between 0% and 100%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Monash IVF Group (ASX:MVF) has a ROC % of 4.31% as of Dec. 2025. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Monash IVF Group and its competitors.
Is Monash IVF Group's ROC % too high?
Monash IVF Group's current ROC % is 4.31%. Overall, Monash IVF Group has a GF Score™ of 78/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Monash IVF Group's ROC % compare to TMO and DHR?
Monash IVF Group's ROC % of 4.31% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC % for a Medical Diagnostics & Research company?
A good ROC % depends on the Medical Diagnostics & Research industry context. However, ROC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC % mean?
A high ROC % can signal that a stock is expensive relative to its fundamentals. Return on capital is the ratio of current-period net income to average two-period capital. View historical data on Monash IVF Group and its competitors. Monash IVF Group's current ROC % is 4.31%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Monash IVF Group stock overvalued right now?
Based on GuruFocus' analysis, Monash IVF Group (ASX:MVF) is currently considered Possible Value Trap. The stock's GF Value™ is A$1.39, compared to a current price of A$0.71 — trading 48.9% below its estimated fair value. The current ROC % is 4.31%. Monash IVF Group's overall GF Score™ is 78/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC % calculated?
ROC % is calculated from a company's financial statements. For Monash IVF Group (ASX:MVF), the current ROC % is 4.31% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Monash IVF Group (ASX:MVF) Overvalued in 2026?
Based on GuruFocus' analysis, Monash IVF Group stock appears to be undervalued.
The current stock price of A$0.71 is trading 48.9% below its estimated GF Value™ of A$1.39.
GuruFocus considers Monash IVF Group to be Possible Value Trap.
Key valuation signals for ASX:MVF:
ROC %: 4.31%
GF Value™: A$1.39 vs. price of A$0.71 (48.9% below fair value)
No single metric tells the full story. See the ASX:MVF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Monash IVF Group Ltd is a provider of fertility services, specializing in Assisted Reproductive Services (ARS) and genetic care across Australia and South East Asia. The Group operates two main segments: Australia IVF and Ultrasound, which offer ARS, ultrasound, and related women's health services, and International IVF, which provides assisted reproductive care in South East Asia. The majority of revenue is generated from the Australian segment through its brands such as Fertility Solutions, KL Fertility, Monash IVF, Repromed, and others.
78GF Score
Get the complete analysis for ASX:MVF
ROC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:MVF has been successfully added to your 
